Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Neuroimmunomodulation ; 24(4-5): 276-281, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29510394

RESUMEN

Prompted by findings suggesting immune instability in infantile bilateral striatal necrosis (IBSN), we evaluated levels of proinflammatory (tumor necrosis factor α, interleukin [IL]-1ß, IL-6, interferon [IFN]γ) and anti-inflammatory (IL-10 and IL-1ra) cytokines produced by peripheral blood mononuclear cells (PBMC) from 6 children with IBSN and 11 age-matched controls. Compared to controls, non-stimulated PBMC from the IBSN group produced a significantly lower level of IL-1ra (by 38%; p < 0.001) and significantly lower levels of TNFα, IL-1ß, and IFNγ (by 36% [p < 0.001], 25% [p = 0.06], and 32% [p < 0.02]) under PBMC stimulation. The severe cachexia manifesting shortly after IBSN onset may impair the immunological state, placing patients at risk of death from hyperpyrexia and sepsis.


Asunto(s)
Citocinas/sangre , Citocinas/inmunología , Leucocitos Mononucleares/inmunología , Leucocitos Mononucleares/metabolismo , Degeneración Estriatonigral/congénito , Adolescente , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Degeneración Estriatonigral/sangre , Degeneración Estriatonigral/diagnóstico , Degeneración Estriatonigral/inmunología
2.
J Neurol ; 249(9): 1206-10, 2002 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12242540

RESUMEN

Multiple System Atrophy (MSA) and idiopathic Parkinson's disease (PD) can be difficult to distinguish. There is an ongoing debate about the diagnostic value of the growth-hormone response to clonidine (CGH-test) in PD and MSA. We investigated whether the CGH-test can identify individual patients in the early stages of PD (n = 21) and Striatonigral Degeneration (SND, n = 11), a particular variety of MSA. Patients were diagnosed on the basis of clinical criteria and IBZM-SPECT. Clonidine induced a greater total serum growth-hormone production in PD than in SND (p = 0.01). However, taking the difference in prevalence of PD and SND into account, and because of the low likelihood ratios of the test, an increase of GH after clonidine increases the pre-test probability for PD by about only 5 %, while an absent response of GH also increases the pre-test probability for SND by about 5 %. We conclude that the CGH-test discriminates between groups of patients with PD and SND, but has little practical diagnostic value for identifying individual patients.


Asunto(s)
Clonidina , Hormona del Crecimiento/metabolismo , Enfermedad de Parkinson/diagnóstico , Degeneración Estriatonigral/diagnóstico , Anciano , Análisis de Varianza , Distribución de Chi-Cuadrado , Diagnóstico Diferencial , Hormona del Crecimiento/sangre , Humanos , Persona de Mediana Edad , Enfermedad de Parkinson/sangre , Estadísticas no Paramétricas , Degeneración Estriatonigral/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA